gunhan gurman

gunhan gurman

Ankara Üniversitesi

H-index: 22

Asia-Turkey

About gunhan gurman

gunhan gurman, With an exceptional h-index of 22 and a recent h-index of 12 (since 2020), a distinguished researcher at Ankara Üniversitesi, specializes in the field of hematology, hematologic oncology, Stem cell transplantation, regenerative medicine, adoptive immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

A novel hypothesis: certain KIR/cognate ligand containing genotypes differ in frequency among patients with myeloma and have an effect on age of disease onset

Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center Experience on Efficacy, Safety …

Hematolojik Hastalıklarda Kullanımı

Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPS/REFRACTORY LYMPHOMA PATIENTS: A SINGLE CENTER EXPERIENCE

Eltrombopag for the treatment of poor graft function following haematopoietic cell transplantation: real-life data

P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

gunhan gurman Information

University

Position

___

Citations(all)

2283

Citations(since 2020)

759

Cited By

1863

hIndex(all)

22

hIndex(since 2020)

12

i10Index(all)

49

i10Index(since 2020)

16

Email

University Profile Page

Ankara Üniversitesi

Google Scholar

View Google Scholar Profile

gunhan gurman Skills & Research Interests

hematology

hematologic oncology

Stem cell transplantation

regenerative medicine

adoptive immunotherapy

Top articles of gunhan gurman

Title

Journal

Author(s)

Publication Date

A novel hypothesis: certain KIR/cognate ligand containing genotypes differ in frequency among patients with myeloma and have an effect on age of disease onset

Clinical Lymphoma Myeloma and Leukemia

Meral Beksac

Hasan Yalim Akin

Guldane Cengiz Seval

Pinar Yurdakul Mesutoglu

Rıdvan Goksel Anliacik

...

2023/5/1

Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center Experience on Efficacy, Safety …

Clinical Lymphoma Myeloma and Leukemia

Meral Beksac

Guldane Cengiz Seval

Derya Koyun

Pervin Topcuoglu

Meltem-Kurt Yuksel

...

2023/3/1

Hematolojik Hastalıklarda Kullanımı

Turkiye Klinikleri Hematology-Special Topics

Günhan GÜRMAN

2023

Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

Blood

Derya Koyun

Uğur Şahin

Güldane Cengiz Seval

Deniz Gören Şahin

Ayla Gökmen

...

2023/11/28

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPS/REFRACTORY LYMPHOMA PATIENTS: A SINGLE CENTER EXPERIENCE

Acta Haematologica

Thomas Weber

Sunday Ocheni

Mascha Binder

Sebastian Theurich

Christof Scheid

...

2013/4/1

Eltrombopag for the treatment of poor graft function following haematopoietic cell transplantation: real-life data

Balkan medical journal

Ekin Kırcalı

Güldane Cengiz Seval

Cemaleddin Öztürk

Hülya Yılmaz

Derya Koyun

...

2023/1

P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

HemaSphere

M Beksac

G Cengiz Seval

S Civriz Bozdag

SK Toprak

M Kurt Yuksel

...

2023/5/1

The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes

Blood

Derya Koyun

Guldane Cengiz

Sinem Civriz Bozdag

Selami Kocak Toprak

Pervin Topçuoğlu

...

2022/11/15

The efficacy and safety of second allogeneic hematopoietic stem cell transplantation.

Selami Kocak Toprak

Ekin Kırcalı

Guldane Cengiz Seval

Sinem Civriz Bozdag

Meltem Kurt Yuksel

...

2022/6/1

Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?

Ekin Kırcalı

Gül Yavuz Ermiş

Cemaleddin Öztürk

Hülya Yilmaz

Guldane Cengiz Seval

...

2022/3

Allogeneic hematopoietic cell transplantation in patients with CML chronic phase in the era of third generation tyrosine kinase inhibitors: a retrospective study by the Chronic …

Bone Marrow Transplantation

Mitja Nabergoj

Katya Mauff

Dietrich Beelen

Arnold Ganser

Nicolaus Kröger

...

2022/7

Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT

Jeffrey A Cohen

Laura E Baldassari

Harold L Atkins

James D Bowen

Christopher Bredeson

...

2019/5/1

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Blood, The Journal of the American Society of Hematology

Michael H Albert

Tiarlan Sirait

Dirk-Jan Eikema

Katerina Bakunina

Claudia Wehr

...

2022/10/6

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients

Authorea Preprints

Myriam L Velandia-Romero

Jhann A Arturo

Carolina Coronel-Ruiz

Adriana P Franco-Rodríguez

Eliana P Calvo

...

2023/6/16

Effect of CD34⁺ Total/Myeloid CD34⁺ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell …

Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation

Klara Dalva

Sule Haskologlu

Sevim Dalva-Aydemir

Memnune D Oz

Aydin Ozturk

...

2022/10/1

Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Clinical Lymphoma Myeloma and Leukemia

Zehra Narli Ozdemir

Ekin Kircali

Uğur Şahin

Guldane Cengiz Seval

Sinem Civriz Bozdağ

...

2022/8/1

Are Generic Imatinib Formulations Really as Effective as Originial Imatinib in Chronic Myeloid Leukemia: Real Life Data

Ekin Kırcalı

Güldane Cengiz Seval

Sinem Civriz Bozdağ

Selami Koçak Toprak

Meltem Kurt Yüksel

...

2022/12/9

The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplantation

Ankara Universites Tip Fakultesi Mecmuasi= Journal of Ankara University Faculty of Medicine

Cengiz Seval Güldane

Ekin Kırcalı

Sinem Civriz Bozdağ

Meltem Kurt Yüksel

Pervin Topçuoğlu

...

2021/12/1

Relaps Refrakter Hodgkin Lenfomada Brentuksimab Vedotin Kullanımı: Tek Merkez Deneyimi

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları

Derya KOYUN

Güldane CENGİZ SEVAL

Metin SÖKMEN

Erman AKKUŞ

Erden ATİLLA

...

2021

Trombositozlu Olgularda Terapötik Trombosit Aferezinin Etkinliği

Journal of Ankara University Faculty of Medicine/Ankara Üniversitesi Tip Fakültesi Mecmuasi

Zehra Narlı Özdemir

Uğur Şahin

Sinem Civriz Bozdağ

Meltem Kurt Yüksel

Selami Koçak Toprak

...

2021/9/1

See List of Professors in gunhan gurman University(Ankara Üniversitesi)